KMDA
Price
$7.46
Change
-$0.17 (-2.23%)
Updated
Feb 21 closing price
Capitalization
306.49M
Earnings call today
RGC
Price
$4.50
Change
+$0.40 (+9.76%)
Updated
Feb 21 closing price
Capitalization
50.75M
Ad is loading...

KMDA vs RGC

Header iconKMDA vs RGC Comparison
Open Charts KMDA vs RGCBanner chart's image
Kamada
Price$7.46
Change-$0.17 (-2.23%)
Volume$223.18K
Capitalization306.49M
Regencell Bioscience Holdings
Price$4.50
Change+$0.40 (+9.76%)
Volume$15.55K
Capitalization50.75M
KMDA vs RGC Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. RGC commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and RGC is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (KMDA: $7.46 vs. RGC: $4.50)
Brand notoriety: KMDA and RGC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 95% vs. RGC: 83%
Market capitalization -- KMDA: $306.49M vs. RGC: $50.75M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. RGC’s [@Pharmaceuticals: Other] market capitalization is $50.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileRGC’s FA Score has 0 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • RGC’s FA Score: 0 green, 5 red.
According to our system of comparison, KMDA is a better buy in the long-term than RGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 3 TA indicator(s) are bullish while RGC’s TA Score has 4 bullish TA indicator(s).

  • KMDA’s TA Score: 3 bullish, 5 bearish.
  • RGC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RGC is a better buy in the short-term than KMDA.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а -4.17% price change this week, while RGC (@Pharmaceuticals: Other) price change was +20.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +77.53%, and the average quarterly price growth was +51.31%.

Reported Earning Dates

KMDA is expected to report earnings on May 20, 2025.

RGC is expected to report earnings on Oct 31, 2022.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than RGC($50.8M). KMDA YTD gains are higher at: 22.496 vs. RGC (-8.907). KMDA has higher annual earnings (EBITDA): 22.4M vs. RGC (-4.67M). KMDA has more cash in the bank: 55.6M vs. RGC (306K). RGC has less debt than KMDA: RGC (3.54M) vs KMDA (8.82M). KMDA has higher revenues than RGC: KMDA (143M) vs RGC (0).
KMDARGCKMDA / RGC
Capitalization306M50.8M602%
EBITDA22.4M-4.67M-479%
Gain YTD22.496-8.907-253%
P/E Ratio37.43N/A-
Revenue143M0-
Total Cash55.6M306K18,170%
Total Debt8.82M3.54M249%
FUNDAMENTALS RATINGS
KMDA vs RGC: Fundamental Ratings
KMDA
RGC
OUTLOOK RATING
1..100
841
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
81100
PRICE GROWTH RATING
1..100
4288
P/E GROWTH RATING
1..100
91100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGC's Valuation (55) in the Movies Or Entertainment industry is in the same range as KMDA (62) in the Biotechnology industry. This means that RGC’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's SMR Rating (81) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

KMDA's Price Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for RGC (88) in the Movies Or Entertainment industry. This means that KMDA’s stock grew somewhat faster than RGC’s over the last 12 months.

KMDA's P/E Growth Rating (91) in the Biotechnology industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that KMDA’s stock grew similarly to RGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDARGC
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
68%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL245.55-0.28
-0.11%
Apple
BTC.X96273.920000-303.835940
-0.31%
Bitcoin cryptocurrency
SPY599.94-10.44
-1.71%
SPDR® S&P 500® ETF Trust
GME26.42-0.62
-2.29%
GameStop Corp
TSLA337.80-16.60
-4.68%
Tesla

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and INCR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and INCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-2.23%
INCR - KMDA
28%
Poorly correlated
-0.10%
OGI - KMDA
24%
Poorly correlated
+1.55%
PAHC - KMDA
21%
Poorly correlated
-2.05%
VTRS - KMDA
21%
Poorly correlated
+1.72%
ORGO - KMDA
21%
Poorly correlated
-5.03%
More

RGC and

Correlation & Price change

A.I.dvisor tells us that RGC and CLCFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and CLCFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
+9.76%
CLCFF - RGC
21%
Poorly correlated
+11.22%
QNTM - RGC
21%
Poorly correlated
-8.52%
SBFM - RGC
20%
Poorly correlated
-0.81%
KMDA - RGC
6%
Poorly correlated
-2.23%
IRWD - RGC
6%
Poorly correlated
-4.47%
More